Li‐Hua Lian

2.9k citations
96 papers · 2.4k indexed · h-index 31
Topics
Liver Disease Diagnosis and Treatment (39 papers)Liver physiology and pathology (27 papers)Alcohol Consumption and Health Effects (18 papers)
Partner nations
ChinaSouth KoreaJapan

In The Last Decade

Li‐Hua Lian

91 papers receiving 2.4k citations

Peers

Li‐Hua Lian
Comparison fields: 5 of 109
  • Molecular Biology 1.0k
  • Epidemiology 679
  • Pharmacology 540
  • Hepatology 388
  • Pathology and Forensic Medicine 324
Replace Ji‐Xing Nan with:
Ji‐Xing Nan China
Xiaojiaoyang Li China
Yujing Xia China
Xufeng Tao China
Xia Gong China
Shutao Yin China
Ming Niu China
Zhaofang Bai China
Xiaoying Wang China
Xing Lin China
Li‐Hua Lian relative to Ji‐Xing Nan China Ji‐Xing Nan's profile →
Citations per field
00.5×1.5×
Ji‐Xing Nan · 1×
Citations per year

Countries citing papers authored by Li‐Hua Lian

Since Specialization
Citations

This map shows the geographic impact of Li‐Hua Lian's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Li‐Hua Lian with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Li‐Hua Lian more than expected).

Fields of papers citing papers by Li‐Hua Lian

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Li‐Hua Lian. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Li‐Hua Lian. The network helps show where Li‐Hua Lian may publish in the future.

Co-authorship network of co-authors of Li‐Hua Lian

This figure shows the co-authorship network connecting the top 25 collaborators of Li‐Hua Lian. A scholar is included among the top collaborators of Li‐Hua Lian based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Li‐Hua Lian. Li‐Hua Lian is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 2
2 0
3 0
4 4
5 8
6 5
7 5
8 6
9 6
10 12
11 19
12 13
13 16
14
Dihydroquercetin inhibits mouse hepatic steatosis induced by high fat diet feeding plus acute ethanol binge
1
15 2
16 25
17 102
18 83
19 25
20 47

About Li‐Hua Lian

Li‐Hua Lian is a scholar working on Hepatology, Pharmacology and Biochemistry, having authored 96 papers that have together received 2.4k indexed citations. Recurring topics across this work include Liver Disease Diagnosis and Treatment (39 papers), Liver physiology and pathology (27 papers) and Alcohol Consumption and Health Effects (18 papers). The work is most often cited by research in Pharmacology (540 citations), Hepatology (388 citations) and Complementary and alternative medicine (264 citations). Li‐Hua Lian has collaborated with scholars based in China, South Korea and Japan. Frequent co-authors include Ji‐Xing Nan, Yan‐Ling Wu, Ting Bai, Ying Wan, Quan Jin, Ben‐Wen Cui, Youli Yao, Yong Yang, Ying‐Zi Jiang and Peng Sun. Their work appears in journals such as SHILAP Revista de lepidopterología, Journal of Agricultural and Food Chemistry and British Journal of Pharmacology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026